Clinical trial
Real World Evaluation Among Italian Centers of the Activity and Safety of Fostamatinib in Consecutive Adult Patients With Immune Thrombocytopenia (ITP)
NCT05613296 is registered in ClinicalTrials.gov with Gruppo Italiano Malattie EMatologiche dell'Adulto as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Real World Evaluation Among Italian Centers of the Activity and Safety of Fostamatinib in Consecutive Adult Patients With Immune Thrombocytopenia (ITP)
- Lead sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 5, 2023
- Completion date
- May 31, 2024
- Enrollment
- 95 (actual)
- Sites
- 21
Conditions
As the registry lists them; a condition with its own page is linked.
chronic itp, itp - immune thrombocytopenia, refractory itp